Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone HCl/Bupropion HCl Extended Release

naltrexone hydrochloride / bupropion hydrochloride extended-release · Takeda Pharmaceuticals U.S.A., Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naltrexone HCl/Bupropion HCl Extended Release, covering 2016-04-08 to 2016-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery [Phase 4]

See pricing